2022 J.P. MORGAN HEALTHCARE CONFERENCE
If you were unable to attend live, you can still register to view the sessions on-demand. And you can find all the program details below.
In the sessions, you’ll hear from healthcare leaders address the latest trends and implications across Digital Health, Life Sciences, Healthcare Private Equity (PE) and Hospitals and Health Systems (HHS). Use these insights to develop long-term, effective strategies for establishing deals and funding agreements to make a positive impact in 2022.
WHY ATTEND?
Prominent Speakers
Including executives from PE firms, investment banks, hospitals, health systems and other industry-leading organizations.
6 Substantive Programs
Exploring critical business and legal issues encountered by investors across the healthcare industry. Sessions will address emerging trends in Digital Health, Life Sciences, Healthcare Private Equity – including in Europe – Hospitals and Health Systems, and Health Technology Investing.
Content Here
Content Here
SCHEDULE
(All times in EST)
JANUARY 10, 2022
10:30 am – 12:45 pm
LIFE SCIENCES INVESTMENT FORUM
Due to the rapid pace of change, life sciences companies are being forced to transform their business models, requiring greater focus on therapies or commercial models. Moving forward, companies will continue to use transactions as an important lever of transformation. This forum will address creative dealmaking strategies for growth in biopharma and medical technology as well as business model transformations companies should consider as they enter new deals.
JANUARY 11, 2022
11:00 am – 1:30 pm
DIGITAL HEALTH PIONEERS FORUM
Advancements in digital health technology are driving greater innovation, with leaders looking to data and analytics as the future of patient care. Listen to executives from leading health technology companies for a series of fireside chats on the evolving models disrupting digital health, including the growing role that retail is playing in the space.
JANUARY 12, 2022
11:00 am – 2:00 pm
HEALTHCARE PRIVATE EQUITY LEADERS FORUM
JANUARY 12, 2022
Digital health has never been hotter and investor interest is surging across all stages. From early- to late-stage investments, lines are blurring with increased disruption in the digital health landscape. During this forum, PE and VC leaders will share their approaches to investing in 2022 and beyond.
JANUARY 13, 2022
11:00 am – 1:00 pm
Today’s hospitals and health systems face unprecedented levels of disruption. Hear from prominent health system executives as they share their perspectives on revenue growth strategies, novel partnerships and how the healthcare ecosystem is coming together more than ever before. These leaders will discuss developing trends and how to position your organization for growth to drive change in this fluid environment.
JANUARY 14, 2022
Chief Clinical Strategy Officer
Covera Health
Head of Corporate Development
Kite, a Gilead Company
Chairman and Chief Executive Officer
Agenus
Managing Partner
Lorient Capital
Vice President
Apax Partners
Partner
Grant Avenue Capital
Dan Brillman
Chief Executive Officer & Co-Founder
Unite Us
Christopher Cleary
Vice President, Corporate Development
Medtronic
Managing Director, Head of North America
Cobepa
Partner
Martis Capital
Investment Partner
Arsenal Capital Partners
President
Best Buy Health
Mike Drazin
Chief Financial Officer
Medline
Deputy Chair, EHCPEA
Chair, Mansfield Advisors
Dr. Adaeze Enekwechi
Operating Partner
Welsh, Carson, Anderson & Stowe
Principal
Ampersand Capital Partners
Chief Innovation Officer
One Medical
Senior Managing Director
Farragut Square Group
Partner
TPG Capital
Partner
Deerfield
Partner
7wireVentures
Managing Director
H.I.G. Capital
Managing Director
Cain Brothers
Co-Chief Executive Officer & Executive Chair
Evidation
Chief Integration Officer and SVP, Head of Global BD&L and Alliance Management
MorphoSys
Tom Lee
Chief Executive Officer & Founder
Galileo
Partner
Two Sigma Impact
Senior Vice President
Valtruis, A WCAS Company
Chief Operating Officer and General Counsel
American Investment Council
Chief Strategy Officer
SSM Health
Executive Vice President of External Affairs, Communications and Brand
The Permanente Federation
Global Group Head, Healthcare Investment Banking
Piper Sandler
Dr. Michelle Perugini
Chief Executive Officer & Co-Founder
Presagen
Managing Director
Kaiser Permanente Ventures
Global Chief Medical Officer & VP of Healthcare
Microsoft
Senior Vice President and Chief Strategy Officer
Trinity Health
Executive Vice President and Chief Strategy andTransformation Officer
Atrium
Chief Executive Officer, Transcarent
Founder & Managing Partner, 7wireVentures
Founder and Chief Executive Officer
b.well Connected Health
Katherine Wood
Partner
TPG Capital
Partner
Public Pension Capital
Chief Operating Officer
Rock Health
Co-Chair of Digital Health
McDermott Will & Emery
Partner
McDermott Will & Emery
Partner
McDermott Will & Emery
Partner
McDermott Will & Emery
SHARON LAMB
Partner
McDermott Will & Emery
Co-Head of Private Equity
McDermott Will & Emery
Co-Chair of Digital Health
McDermott Will & Emery
Vice President
McDermott+ Consulting
Co-Chair of Life Sciences
McDermott Will & Emery
DR. STEPHAN RAU
Partner
McDermott Will & Emery
Global Head of Health
McDermott Will & Emery
Co-Chair of Digital Health
McDermott Will & Emery
Co-Head of Private Equity
McDermott Will & Emery
Partner, Life Sciences
Ernst & Young LLP
Global Deals Leader, Life Sciences
Ernst & Young LLP
Principal
EY-Parthenon
US Health Leader
Ernst & Young LLP
Health & Life Sciences Sector Lead
EY-Parthenon U.K.
Chief Economist
EY-Parthenon
US Consulting Digital Health and Smart Health Experience Leader
Ernst & Young LLP
Managing Director
Ernst & Young Capital Advisors, LLC
Principal, Washington Council
Ernst & Young
Principal, Consulting, Digital Health
Ernst & Young LLP
Healthcare Private Equity Leader
EY-Parthenon
US Health Integration and Divestiture Leader
EY-Parthenon
Americas Industry Markets Leader, Health Sciences and Wellness
Ernst & Young LLP
